503 related articles for article (PubMed ID: 34122408)
1. Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma.
Li H; Liu H; Fu H; Li J; Xu L; Wang G; Wu H
Front Immunol; 2021; 12():648812. PubMed ID: 34122408
[TBL] [Abstract][Full Text] [Related]
2. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective.
Jia W; Yao Q; Wang Y; Mao Z; Zhang T; Li J; Nie Y; Lei X; Shi W; Song W
Front Immunol; 2022; 13():1007426. PubMed ID: 36189217
[TBL] [Abstract][Full Text] [Related]
4. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
[TBL] [Abstract][Full Text] [Related]
5. Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma.
Shen YC; Hsu CL; Jeng YM; Ho MC; Ho CM; Yeh CP; Yeh CY; Hsu MC; Hu RH; Cheng AL
J Hepatol; 2020 Mar; 72(3):489-497. PubMed ID: 31634533
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
Sofopoulos M; Fortis SP; Vaxevanis CK; Sotiriadou NN; Arnogiannaki N; Ardavanis A; Vlachodimitropoulos D; Perez SA; Baxevanis CN
Cancer Immunol Immunother; 2019 Nov; 68(11):1733-1745. PubMed ID: 31598757
[TBL] [Abstract][Full Text] [Related]
7. Tertiary Lymphoid Structures, Immune Response, and Prognostic Relevance in Non-Small Cell Lung Cancer.
Giatromanolaki A; Chatzipantelis P; Contrafouris CA; Koukourakis MI
Cancer Invest; 2023 Jan; 41(1):48-57. PubMed ID: 36239379
[TBL] [Abstract][Full Text] [Related]
8. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
9. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
10. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
11. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
[TBL] [Abstract][Full Text] [Related]
12. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY
PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
[TBL] [Abstract][Full Text] [Related]
17. Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.
Engelhard VH; Rodriguez AB; Mauldin IS; Woods AN; Peske JD; Slingluff CL
J Immunol; 2018 Jan; 200(2):432-442. PubMed ID: 29311385
[TBL] [Abstract][Full Text] [Related]
18. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
Front Immunol; 2021; 12():612139. PubMed ID: 33679751
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.
Chen KJ; Zhou L; Xie HY; Ahmed TE; Feng XW; Zheng SS
Med Oncol; 2012 Sep; 29(3):1817-26. PubMed ID: 21678026
[TBL] [Abstract][Full Text] [Related]
20. Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules.
Meylan M; Petitprez F; Lacroix L; Di Tommaso L; Roncalli M; Bougoüin A; Laurent A; Amaddeo G; Sommacale D; Regnault H; Derman J; Charpy C; Lafdil F; Pawlotsky JM; Sautès-Fridman C; Fridman WH; Calderaro J
Clin Cancer Res; 2020 Aug; 26(16):4381-4389. PubMed ID: 32269054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]